Patents by Inventor Charlotte Hojer-Pedersen

Charlotte Hojer-Pedersen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11666635
    Abstract: The present invention pertains in general to the field of the stabilization of gonadotropin formulations, in particular liquid formulations of gonadotropins. The stabilization is achieved by a particular combination of excipients, preferably arginine and methionine. In a preferred embodiment, the formulation does not comprise a buffer.
    Type: Grant
    Filed: September 14, 2020
    Date of Patent: June 6, 2023
    Assignee: Ferring B.V.
    Inventors: Helen Ulrika Sjögren, Charlotte Hojer-Pedersen
  • Publication number: 20210236600
    Abstract: The present invention pertains in general to the field of the stabilization of gonadotropin formulations, in particular liquid formulations of gonadotropins. The stabilization is achieved by a particular combination of excipients, preferably arginine and methionine. In a preferred embodiment, the formulation does not comprise a buffer.
    Type: Application
    Filed: September 14, 2020
    Publication date: August 5, 2021
    Inventors: Helen Ulrika Sjögren, Charlotte Hojer-Pedersen
  • Patent number: 10792334
    Abstract: The present invention pertains in general to the field of the stabilization of gonadotropin formulations, in particular liquid formulations of gonadotropins. The stabilization is achieved by a particular combination of excipients, preferably arginine and methionine. In a preferred embodiment, the formulation does not comprise a buffer.
    Type: Grant
    Filed: February 24, 2017
    Date of Patent: October 6, 2020
    Assignee: Ferring B.V.
    Inventors: Helen Ulrika Sjögren, Charlotte Højer-Pedersen
  • Publication number: 20190060409
    Abstract: The present invention pertains in general to the field of the stabilization of gonadotropin formulations, in particular liquid formulations of gonadotropins. The stabilization is achieved by a particular combination of excipients, preferably arginine and methionine. In a preferred embodiment, the formulation does not comprise a buffer.
    Type: Application
    Filed: February 24, 2017
    Publication date: February 28, 2019
    Inventors: Helen Ulrika Sjögren, Charlotte Højer-Pedersen